| Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing IF Orlando, JM Shine, TW Robbins, JB Rowe, C O’Callaghan Neuroscience & Biobehavioral Reviews 149, 105167, 2023 | 33 | 2023 |
| Abnormal higher-order network interactions in Parkinson’s disease visual hallucinations JB Tan, EJ Müller, IF Orlando, NL Taylor, DS Margulies, J Szeto, ... Brain 147 (2), 458-471, 2024 | 7 | 2024 |
| Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia IF Orlando, C O’Callaghan, A Lam, AC McKinnon, JBC Tan, ... Molecular Psychiatry 29 (2), 402-411, 2024 | 5 | 2024 |
| Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease C O'Callaghan, F Hezemans, N Subramaniam, R Ye, K Tsvetanov, ... | 3 | 2024 |
| Noradrenergic modulation of saccades in Parkinson’s disease IF Orlando, FH Hezemans, R Ye, AG Murley, N Holland, R Regenthal, ... Brain Communications 6 (5), fcae297, 2024 | 1 | 2024 |
| Pupil and eye tracking measures as a tool for detection and intervention in neurodegeneration C O’Callaghan, FH Hezemans, R Ye, I Orlando, L Passamonti, JB Rowe Alzheimer's & Dementia 18, e065889, 2022 | 1 | 2022 |
| Cerebellar and Subcortical Contributions to Working Memory Manipulation JBC Tan, IF Orlando, C Whyte, AG Bryant, BR Munn, G Baracchini, M King, ... bioRxiv, 2025.02. 20.639399, 2025 | | 2025 |
| Dopamine alters functional gradients in Parkinson’s disease IF Orlando, JB Tan, NL Taylor, V Medel, G Wainstein, SJG Lewis, ... | | 2024 |
| Neural correlates of dual task touchscreen performance in Parkinson’s disease J De Vleeschhauwer, N D'cruz, I Orlando, J Tan, E Nackaerts, ... International Congress of Parkinson’s Disease and Movement Disorders, Date …, 2023 | | 2023 |
Claire O'CallaghanUniversity of SydneyEmail được xác minh tại sydney.edu.au